WELCOME TO VISIA LAB
VISIA LAB is an emerging company engaged in the design, development and production of hardware and software solutions for IVD clinical laboratory diagnostics, with various fields of application, including cytodiagnostics & cytogenetics, digital and tele-pathology, immunoassays and in particular immunofluorescence assays, big data and genetic testing in general.
Founded in 2020, VISIA LAB is a global business-to-business technology company OEM-oriented.
VISIA LAB born to create new, innovative and transformative diagnostic platforms and products.
The company's mission and purpose is to create new diagnostic technologies and models of patient care thanks to the most innovative technologies and the know-how used.
VISIA LAB Quality Management System complies with the following internationally recognized standards:
EN ISO 13485: 2016
More than 25 years of inherited experience
VISIA LAB was born from VISIA Imaging S.r.l .; the latter was founded in 1993 by a small group of highly specialized engineers in the development of image analysis software for microscopy. Born from experience and tradition, the company is committed to growing in its main areas of activity.
Passion For Innovation
A qualified team between young and experienced professionals works proactively to create high quality products and provide innovative solutions for demanding and demanding markets.
VISIA LAB is organized in cross-functional departments.
Multidisciplinary groups of workers from different professional or academic backgrounds collaborate on specific projects to increase creativity and share knowledge resulting in higher quality and faster solutions as a result.
About 50% of the employees are graduates in various disciplines
Multidisciplinary approach: widespread education in the fields of electronics, mechanical and computer engineering, biology, big data and other disciplines
About 30% of human resources form the strategic research and development group, out of the total staff
About 15% of gross annual revenue is constantly invested in research and development
About 35% of the resources are female